Target intelligence / Profile preview

60S ribosomal protein L17 (RPL17)

Target
RPL17
Molecular classification
Other, ribosomal protein, L22P family
01

Overview

60S ribosomal protein L17 (RPL17) is a component of the large (60S) subunit of the cytoplasmic ribosome and belongs to the L22P family of ribosomal proteins. It is crucial for ribosome architecture, interacting with rRNA to stabilize the polypeptide exit tunnel, and is essential for pre-rRNA processing during ribosome biogenesis. RPL17 is a structural protein required for the normal maturation of the 60S ribosomal subunit and plays roles in protein synthesis in all cells. Deficiency of RPL17 disrupts rRNA processing, leading to defective ribosome assembly and reduced protein synthesis capability, with implications for disorders such as anemia and pancytopenia[1][2][3][4].

Other names
ribosomal protein L17large ribosomal subunit protein uL22uL22rpL23L17RPL2360S ribosomal protein L23DBA22gene encoding putative NFkB activating protein
02

Biological functions

Protein synthesisRibosome biogenesisRNA bindingStructural constituent of ribosome
03

Disease associations

Macrocytic anemiaPancytopenia

Beyond the preview

Go deeper on 60S ribosomal protein L17 (RPL17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 60S ribosomal protein L17 (RPL17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call